GlassScriptPhysician profile
William A Currie
NPI 1093713596
$2,045.94
in general payments reported to CMS, 2019-2025
15 companies · $324 in 2025
The $324 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.18 · 2020: $38.99 · 2021: $117 · 2022: $485 · 2023: $645 · 2024: $397 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,366.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,411.51 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Regeneron Healthcare Solutions, INC. | $162.78 | 2021-2023 | Dupixent |
| Amgen INC. | $139.71 | 2024-2025 | Evenity, Tavneos |
| Abbvie INC. | $125.56 | 2025 | |
| Glaxosmithkline, LLC. | $38.18 | 2019 | |
| Amarin Pharma, INC. | $27.20 | 2021-2022 | |
| Allergan, INC. | $23.54 | 2020 | |
| Lilly USA, LLC | $17.30 | 2023 | Jardiance |
| Novo Nordisk INC | $16.87 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.78 | 2022 | |
| Intercept Pharmaceuticals, INC. | $15.45 | 2020 | |
| Inspire Medical Systems, INC. | $14.18 | 2025 | Inspire |
| Biohaven Pharmaceuticals, INC. | $13.92 | 2021 | |
| Pacira Therapeutics, INC. | $12.02 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Currie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.